Human papillomavirus and cervical cancer (Q58279986)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Human papillomavirus and cervical cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

main subject

cervix uterine cancer

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Silvia Franceschi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Mark H Einstein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Henry C Kitchener

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

23 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

9895

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

889-899

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Prevalence of HPV infection among females in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Human papillomavirus infection in a population-based sample of women in Algiers, Algeria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

HPV infection in women with and without cervical cancer in Conakry, Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

The cervical cancer epidemic that screening has prevented in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

The carcinogenicity of human papillomavirus types reflects viral evolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

The papillomavirus life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

The natural history of cervical HPV infection: unresolved issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

The biological properties of E6 and E7 oncoproteins from human papillomaviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Pathology and epidemiology of HPV infection in females

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

The role of TP53 in Cervical carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Biological activities and molecular targets of the human papillomavirus E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

A role for HPV16 E5 in cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Immunosuppressive tumor microenvironment in cervical cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Interaction of human papillomaviruses with the host immune system: a well evolved relationship.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Genetic variants in TAP are associated with high-grade cervical neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Cervical intraepithelial neoplasia is associated with genital tract mucosal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Chapter 6: Immunosuppression and co-infection with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Clinician's guide to human papillomavirus immunology: knowns and unknowns

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Surgery followed by Persistence of High-Grade Squamous Intraepithelial Lesions Is Associated with the Induction of a Dysfunctional HPV16-Specific T-Cell Response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Beyond cervical cancer: burden of other HPV-related cancers among men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

HPV vaccine against anal HPV infection and anal intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Adolescent and young adult HPV vaccination in Australia: achievements and challenges.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Papillomavirus vaccines in perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

The role of cost-effectiveness in U.S. vaccination policy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Economic evaluation of human papillomavirus vaccination in developed countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Papillomavirus prophylactic vaccines: established successes, new approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

A multimeric L2 vaccine for prevention of animal papillomavirus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Development of therapeutic HPV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Vaccine strategies for human papillomavirus-associated cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

HPV screening for cervical cancer in rural India

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960022-7

7 January 2021

10.1016/S0140-6736(13)60022-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23618600%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference